Biopharmaceuticals
Advanced Accelerator Applications (AAA), is a Novartis Company focused on transforming the lives of patients through their leading innovation in nuclear medicine. AAA is dedicated to developing treatments for several leading types of cancer through the application of precision, targeted radioligand therapy. Their goal is to leverage industry leading pipelines to unlock the benefit of radioligand therapy across different tumor types and ultimately reimagine nuclear medicine.
Sidonie Golombowski-Daffner, Ph.D.,
Nice Insight/That’s Nice
89 Fifth AvenueFifth FloorNew YorkNY 10003-3020
New York – San Diego – ChicagoLondon – Frankfurt – Shanghai
Nice Insight is the market research division of That’s Nice LLC, the leading marketing agency serving life sciences.